De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

AppliedLtd Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

AppliedLtd heeft een totaal eigen vermogen van ¥10.4B en een totale schuld van ¥652.0M, wat de schuld-eigenvermogensverhouding op 6.3% brengt. De totale activa en totale passiva bedragen respectievelijk ¥18.1B en ¥7.7B. De EBIT AppliedLtd is ¥2.1B waardoor de rentedekking 531.3 is. Het heeft contanten en kortetermijnbeleggingen van ¥3.8B.

Belangrijke informatie

6.3%

Verhouding schuld/eigen vermogen

JP¥652.00m

Schuld

Rente dekkingsratio	531.3x
Contant	JP¥3.77b
Aandelen	JP¥10.42b
Totaal verplichtingen	JP¥7.66b
Totaal activa	JP¥18.07b

Recente financiële gezondheidsupdates

Does AppliedLtd (TYO:3020) Have A Healthy Balance Sheet?

Apr 30

We Think AppliedLtd (TYO:3020) Can Manage Its Debt With Ease

Jan 20

Recent updates

There's No Escaping Applied Co.,Ltd.'s (TSE:3020) Muted Earnings

Aug 06

AppliedLtd (TSE:3020) Is Posting Promising Earnings But The Good News Doesn’t Stop There

May 22

AppliedLtd (TYO:3020) Has Gifted Shareholders With A Fantastic 141% Total Return On Their Investment

Jan 05

Applied Co., Ltd.'s (TYO:3020) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Dec 21

Does Applied (TYO:3020) Have The DNA Of A Multi-Bagger?

Dec 06

Applied's (TYO:3020) Earnings Are Growing But Is There More To The Story?

Nov 21

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ¥12.4B ) 3020 } overtreffen de korte termijn passiva ( ¥6.8B ).

Langlopende schulden: De kortetermijnactiva 3020 ( ¥12.4B ) overtreffen de langetermijnschulden ( ¥818.0M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 3020 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van 3020 is de afgelopen 5 jaar gedaald van 71.4% naar 6.3%.

Schuldendekking: De schuld van 3020 wordt goed gedekt door de operationele kasstroom ( 218.9% ).

Rentedekking: De rentebetalingen op de schuld van 3020 worden goed gedekt door EBIT ( 531.3 x dekking).

AppliedLtd Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Does AppliedLtd (TYO:3020) Have A Healthy Balance Sheet?

We Think AppliedLtd (TYO:3020) Can Manage Its Debt With Ease

Recent updates

Upcoming dividend of JP¥20.00 per share

There's No Escaping Applied Co.,Ltd.'s (TSE:3020) Muted Earnings

Investor sentiment deteriorates as stock falls 23%

Applied Co.,Ltd. to Report Q3, 2025 Results on Feb 14, 2025

AppliedLtd (TSE:3020) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Applied Co.,Ltd., Annual General Meeting, Jun 27, 2024

Upcoming dividend of JP¥60.00 per share

Applied Co.,Ltd. to Report Fiscal Year 2024 Results on May 14, 2024

Third quarter 2024 earnings released: EPS: JP¥149 (vs JP¥130 in 3Q 2023)

Applied Co.,Ltd. to Report Q3, 2024 Results on Feb 14, 2024

Second quarter 2024 earnings released: EPS: JP¥103 (vs JP¥76.95 in 2Q 2023)

Applied Co.,Ltd. to Report Q2, 2024 Results on Nov 14, 2023

Upcoming dividend of JP¥20.00 per share at 3.4% yield

First quarter 2024 earnings released: EPS: JP¥91.01 (vs JP¥42.17 in 1Q 2023)

Full year 2023 earnings released: EPS: JP¥406 (vs JP¥549 in FY 2022)

Applied Co.,Ltd., Annual General Meeting, Jun 29, 2023

Upcoming dividend of JP¥60.00 per share at 2.2% yield

Third quarter 2023 earnings released: EPS: JP¥130 (vs JP¥150 in 3Q 2022)

Second quarter 2023 earnings released: EPS: JP¥76.95 (vs JP¥125 in 2Q 2022)

No independent directors

Upcoming dividend of JP¥20.00 per share

Applied Co., Ltd. to Report Q3, 2023 Results on Feb 14, 2023

First quarter 2023 earnings released: EPS: JP¥42.17 (vs JP¥127 in 1Q 2022)

Full year 2022 earnings released: EPS: JP¥549 (vs JP¥583 in FY 2021)

Applied Co., Ltd., Annual General Meeting, Jun 29, 2022

No independent directors

Applied Co., Ltd. to Report Fiscal Year 2022 Results on May 13, 2022

Upcoming dividend of JP¥25.00 per share

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS JP¥125 (vs JP¥118 in 2Q 2021)

Upcoming dividend of JP¥15.00 per share

First quarter 2022 earnings released: EPS JP¥127 (vs JP¥182 in 1Q 2021)

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS JP¥583 (vs JP¥444 in FY 2020)

Does AppliedLtd (TYO:3020) Have A Healthy Balance Sheet?

Upcoming dividend of JP¥25.00 per share

Returns On Capital - An Important Metric For AppliedLtd (TYO:3020)

Applied Co.,Ltd. to Report Fiscal Year 2021 Results on May 14, 2021

Third quarter 2021 earnings released: EPS JP¥86.92 (vs JP¥153 in 3Q 2020)

Why Applied Co.,Ltd. (TYO:3020) Should Be In Your Dividend Portfolio

We Think AppliedLtd (TYO:3020) Can Manage Its Debt With Ease

New 90-day low: JP¥2,936

AppliedLtd (TYO:3020) Has Gifted Shareholders With A Fantastic 141% Total Return On Their Investment

New 90-day low: JP¥2,950

Applied Co., Ltd.'s (TYO:3020) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

New 90-day low: JP¥3,330

Does Applied (TYO:3020) Have The DNA Of A Multi-Bagger?

Applied's (TYO:3020) Earnings Are Growing But Is There More To The Story?

Market pulls back on stock over the past week

New 90-day low: JP¥3,540

Second quarter 2021 earnings released: EPS JP¥118

New 90-day high: JP¥4,820

Upcoming Dividend of JP¥15.00 Per Share

First quarter earnings released

Applied Co., Ltd. announced that it has received ¥3.32958 million in funding from Daiwa Securities Co., Ltd., Investment Arm

Applied Co., Ltd. announced that it expects to receive ¥3.32958 million in funding from Daiwa Securities Co., Ltd., Investment Arm

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven